Editorial Staff

Origin of COVID-19: As Animal Source Evidence Eludes Scientists, Lab Leak Hypothesis Gains Purchase

/in , , , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

This week on Hubwonk, host Joe Selvaggi talks with author and former New York Times science journalist Nicholas Wade about his recent article in the Bulletin of the Atomic Scientists on the possible origins of the SARS2 virus that caused the COVID-19 pandemic. In their conversation, they consider the possibility that, absent finding evidence of a natural jump from animals, the SARS2 virus may have come from a lab.

Guest:

Nicholas Wade is a science writer, editor, and author who has worked on the staff of Nature, Science, and, for 30 years, the New York Times. Wade was born in Aylesbury, England, and educated at Eton and at King’s College, Cambridge, where he studied natural sciences.

Get new episodes of Hubwonk in your inbox!

Related Posts

Income Inequality Explored: Wage Gap Overlooks Government Intervention

This week on Hubwonk, host Joe Selvaggi talks with John F. Early, economist and author of the newly released book, The Myth of American Inequality, about the history of income inequality, its true size, and trends. They also discuss how census data used in policy decision-making misses nearly all the effects of government intervention and distorts the truth about the income American families actually have to spend.

Khan Academy’s Sal Khan & ASU Prep Digital’s Amy McGrath on the Khan World School @ ASU Prep

This week on “The Learning Curve," Cara Candal and Gerard Robinson talk with Sal Khan, founder and CEO of Khan Academy, and Amy McGrath, the Chief Operating Officer of ASU Prep and Deputy Vice President of ASU Educational Outreach.

Collegiate Kangaroo Courts: Title IX Rewrite Expels Free Expression and Due Process

This week on Hubwonk, host Joe Selvaggi talks with Pacific Legal Foundation Senior Fellow Alison Somin about the Biden Administration’s proposed modifications to Title IX fair treatment guidelines, challenging principles of free speech and due process, and potentially chilling the culture of free debate in American universities.

Hoover at Stanford’s Dr. Niall Ferguson on Britain, the English-Speaking World, & the Politics of Catastrophe

This week on “The Learning Curve," Cara Candal and Gerard Robinson talk with Dr. Niall Ferguson, the Milbank Family Senior Fellow at the Hoover Institution, Stanford University, and a senior faculty fellow of the Belfer Center for Science and International Affairs at Harvard. He is the author of 16 books, including "Doom: The Politics of Catastrophe."

Train Wreck Averted: Labor Ties American Economy to the Tracks

This week on Hubwonk, host Joe Selvaggi talks with Dominic Pino, Thomas L. Rhodes Fellow at the National Review Institute, about his research and writing on the recently averted rail strike, including how the rail industry is organized, what labor’s demands were, and how the prospect of a nationwide rail strike exposed vulnerabilities within the American economy.

Independent Institute’s Dr. Bill Evers & Ze’ev Wurman on K-12 STEM Education & California’s Woke Math

This week on “The Learning Curve," Cara Candal and Gerard Robinson talk with Dr. Bill Evers and Ze'ev Wurman, of the Independent Institute, about the challenges of ensuring all students have access to quality K-12 math and science education in California and across the U.S.

Gargantuan Graduation Gift: Biden Writes Check From Taxpayers To College Grads

This week on Hubwonk, host Joe Selvaggi talks with Dr. Beth Akers, AEI Senior Fellow, about the recent presidential executive order to cancel an estimated $500 billion in outstanding student debt. They explore who benefits, who pays, and the likely effects on tuition and the borrowing habits of future students.

Patrick Anquetil on America’s Freedom to Innovate

This week on JobMakers, host Denzil Mohammed talks with Dr. Patrick Anquetil, immigrant from France and co-founder and CEO of Portal Instruments in Cambridge, Massachusetts, a clinical stage medical device company developing a needle-free drug delivery platform. As Patrick shares, there was no way he could have started a business like this in his home country.